ICL 10.0: Autoimmune Diseases Flashcards

1
Q

what causes autoimmune diseases?

A

loss of self tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the two categories of autoimmune diseases?

A
  1. organ specific

2. organ nonspecific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are organ specific autoimmune diseases?

A

autoimmunity is directed against a component of a single organ, thus, the resulting clinical symptoms are related to dysfunction of that organ

ex. Hashimoto’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are organ nonspecific autoimmne diseases?

A

autoimmunity directed at antigens that are dispersed in many organs

ex. SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathogenesis of autoimmune diseases?

A

the pathogenesis involves T cell recognition of specific autoantigen resulting in T and B cell activation and the generation of autoantibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

autoimmunity in the pancreas causes what?

A

type I diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

autoimmunity in the stomach causes what?

A

pernicious anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

autoimmunity in the CNS causes what?

A

multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

autoimmunity in the thyroid causes what?

A

Grave’s diseases

Hashimoto’s thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

autoimmunity in the muscles causes what?

A

myasthenia gravis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is pernicious anemia?

A

results from malabsorption of vitamin B12 that is caused by intrinsic factor deficiency due to one of two mechanisms

B12 has to bind to IF in the stomach in order to be absorbed from the gut into the bloodstream

parietal cells secrete IF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the two mechanisms in pernicious anemia that can cause intrinsic factor deficiency?

A
  1. progressive autoimmune destruction of parietal cells of the gastric mucosa leading to intrinsic factor deficiency
  2. the presence of blocking autoantibodies to the intrinsic factor that prevents the formation of vitamin B12-intrinsic factor complex

95% of patients have demonstrable anti-parietal cell antibodies &/or anti-Intrinsic factor antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the clinical presentation of pernicious anemia?

A
  1. low Hb
  2. unsteady gait, mental changes, confusion, impaired memory, inappropriate behavior
  3. high MCV
  4. low B12 levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is myesthenia gravis?

A

an autoimmune disorder that affects the neuromuscular junctions leading to weakness of voluntary muscles with repeated use

the autoantibody involved is anti-ACh receptor antibodies

the autoantibodies target ACh receptors and if ACh can’t bind, then the muscles can’t depolarize and there’s no muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which diseases are examples of organ-nonspecific autoimmune diseases?

A
  1. Rheumatoid Arthritis (RA)‏
  2. Systemic Lupus Erythematosus (SLE)‏
  3. Scleroderma, Systemic Sclerosis (SSc)‏
  4. Sjögren’s Syndrome (SS)‏
  5. Polymyositis/Dermatomyositis (P/DM)‏
  6. Vasculitis
  7. Seronegative spondyloarthropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are constitutional symptoms?

A

aka systemic symptoms

malaise, low grade fever, and weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what lab results would you see with systemic inflammation?

A
  1. elevated RBC sedimentation rate
  2. elevated C-reactive protein (CRP)
  3. autoantibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the two categories of autoantibodies?

A
  1. disease nonspecific antibodies

2. disease specific autoantibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

which autoantibodies are disease non-specific?

A

antinuclear antibodies (ANA)

rheumatoid factor (RF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what concentration is a negative titer?

A

<1:40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what concentration is a low antibody level titer?

A

1:40 to 1:80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what concentration is an elevated antibody level titer?

A

> 1:80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are the 5 titer patterns?

A
  1. peripheral/rimmed
  2. homogenous
  3. speckled
  4. centromere
  5. nucleolar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what antibody and disease is related to a peripheral/rimmed pattern?

A

antibody: anti-dsDNA
disease: SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what antibody and disease is related to a homogenous pattern?

A

antibody: anti-dsDNA, anti-histone
diseases: RA & SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what antibody and disease is related to a speckled pattern?

A

antibody: SS-A, SS-B, anti-Sm, anti-RNP, anti-Jo-1, anti-Mi-2, anti-Scl-70
diseases: SLE, SSc, PM/DM, Sjogrens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what antibody and disease is related to a centromere pattern?

A

antibody: anti-centromere
disease: SSc

SSc = Systemic Sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is ANA used to test for?

A

super helpful for diagnosing SLE and systemic sclerosis (SSc)

somewhat useful for diagnosing Sjogren’s syndrome and PM/DM

also helpful with identifying:

  1. idiopathic arthritis in kids
  2. distinguishing patients with primary Raynaud’s phenomenon from those with Raynaud’s phenomenon associated with an underlying systemic autoimmune disease
  3. drug induced lupus
  4. autoimmune hepatitis
29
Q

is being ANA positive diagnostic for an autoimmune disease?

A

no!

ANA positivity is not specific for autoimmune diseases

15% of the healthy population is ANA+!

normal people are ANA+ but at low titer concentrations; as the concentration increases ANA is more indicative of autoimmune disease

30
Q

what are rheumatoid factors?

A

disease *nonspecific autoantibodies

RFs are antibodies directed against the Fc fragment of IgGs

RFs are present in 80% of RA patients but they are also present in many other autoimmune diseases and 10% of the healthy population so they are not diagnostic for RA!

31
Q

what is the serum sickness model?

A
  1. an animal (rabbit) is injected intravenously with another animal’s (horse) serum
  2. recipient animal generates antibodies to donor serum
  3. at a certain stage, the recipient develops circulating immune complexes that consist of donor antigens combined with recipient antibodies
  4. IC deposit in the tissues, fixes complement and initiates inflammatory reactions that causes tissue injury

in the one shot serum sickness model surviving animals will have life long immunity to the offending antigen

recurrent serum sickness leads to chronic illness with carditis, nephritis, arthritis and skin rashes

32
Q

what’s the net result of serum sickness?

A

immune complexes depositing in tissues and joints

usually in kidney tissue!

33
Q

what is SLE?

A

a multi-system autoimmune disease associated with genetic and environmental risk factors

SLE is characterized by inflammation in several organ systems and by the production of autoantibodies that participate in immunologically mediated tissue injury

34
Q

what population is SLE most common in?

A

women of childbearing years

specifically non-white ethnic women

African Americans, Asian, Hispanic, and Native Americans are three times more likely to develop SLE than Caucasians and they often have more aggressive form of SLE

35
Q

what is a major cause of death in SLE patients?

A

cardiovascular disease

due to widespread inflammation

36
Q

what are the main symptoms of SLE?

A
  1. fatigue
  2. low grade fever
  3. anorexia/weight loss
37
Q

does SLE have a genetic predisposition?

A

yup

there is a high concordance in monozygotic twins - 25% chance of the second twin getting SLE if the first one has it

5-13% of relatives have disease

38
Q

which gene encodes for SLE?

A

trick question, there is no single lupus gene! the disease is polygeneic

there are at least 40 susceptibility genes that have been identified

39
Q

which genes put people at risk for SLE?

A

HLADR2

HLADR3

HLADR4

HLADR8

these are present in 75% of SLE patients

theses genes are associated with B and T cell activation, apoptosis induction and removal of apoptotic bodies, and clearance of immune complexes

40
Q

what are the effects of SLE on the immune system?

A
  1. activation of innate immunity
  2. loss of tolerance via failed elimination of autoreactive T lymphocytes
  3. polyclonal activation of B cells
  4. defective function of T regulatory cells
  5. delayed clearance of apoptotic cells, resulting in autoantigenic stimulation
  6. defective clearance of circulating immune complexes = tissue damage
  7. deficiency or dysfunction of the early complement components
41
Q

what are the specific antibodies involved in SLE?

A
  1. anti-dsDNA
  2. anti-Sm (Smith)

both are highly specific for SLE

**absence of these antibodies does NOT rule out SLE

42
Q

what changes occur during an SLE flareup?

A

decreased complement because it’s binding to the accumulating immune complexes

increased anti-dsDNA

43
Q

what is used to treat SLE?

A

corticosteroids like prednisone

they help to increase complement levels and decreased anti-dsDNA so that symptoms subside

44
Q

which organs are commonly involved in SLE?

A
  1. CNS
  2. kidneys** 50% of SLE patients have nephritis
  3. eyes and mucous membranes
  4. GI
  5. heart and lungs
  6. skin
  7. hematologic
  8. musculoskeletal
45
Q

what are the symptoms of SLE?

A
  1. fevers
  2. swollen joints
  3. extreme fatigue
  4. skin rashes
  5. anemia

most common, in that order

46
Q

what is the criteria to officially be diagnosed as having SLE?

A

if you have 4/11 of the following, there is a 86% you have SLE

Malar rash

Discoid rash

Photosensitivity

Oral/nasal ulcers

Serositis

Nephritis

Non-erosive arthritis

Cytopenias

Neuropsychiatric

+ ANA

+ Immunoserology

47
Q

how do you treat SLE?

A

there is no cure for SLE, just drugs to modify the course of the disease and alleviate symptoms

Hydroxychloroquine

Methotrexate

Corticosteroids

Mycophenolate mofetil

Cyclophosphamide

Rituximab

Belimumab

IVIG

Plasma exchange

48
Q

what is the mortality of SLE?

A

bimodal mortality

early deaths: infection and renal involvement

later deaths: atherosclerotic disease

49
Q

what is rheumatoid arthritis?

A

a chronic disabling inflammatory arthritis, which is associated with a significant morbidity and an increased mortality

progressive joint destruction and extra-articular manifestations account for the disability and increased mortality

50
Q

what population is RA more common in?

A

3x more common in women than men

51
Q

what 3 signs would make you suspect RA?

A
  1. symptoms lasting for over 6 weeks
  2. inflammatory synovitis
  3. symmetrical and polyarticular swelling
52
Q

which joints are usually not effected by RA?

A

thoracolumbar spine

DIPs of the fingers and IPs of the toes

53
Q

what is the specific autoantibody in RA?

A

anti-CCP

anti-citrullinated cyclic peptide

54
Q

how is peptide cirtullination related to RA?

A

Peptide citrullination is post-translational conversion of arginine to citrulline by peptidylarginine deiminase (PAD)

WBC release PAD during inflammation so peptide citrullination can be seen in any chronic inflammatory process

patients with RA react to citrullinated peptide by forming antibodies “rheumatoid signature”

55
Q

how accurate is anti-CCP in detecting RA?

A

sensitivity: up to 70% of RA patients
specificity: 98% specific for RA

56
Q

which autoantibodies are related to RA?

A
  1. anti-CPP

2. RF

57
Q

how is RA categorized?

A

based on if anti-CPP and/or RF autoantibodies are present

  1. patient with RA may have positive RF and positive CCP antibodies (60%) = most aggressive
  2. positive RF and negative CCP
  3. positive CCP and negative RF
  4. negative RF and negative CCP
58
Q

what are the risk factors for RA?

A
  1. genetics
  2. bacterial or viral agents: parovirus, hepatitis, EBV, rubella
  3. environmental triggers: tobacco,
59
Q

which gene is associated with an increased risk for RA?

A

HLA-DRB1 gene

60
Q

what is the pathology of RA?

A

the pathology of RA extends throughout the synovium and joint

in contrast to the acellular nature of normal synovial fluid, RA synovial fluid is enriched predominantly with neutrophils; but macrophages, T lymphocytes, and dendritic cells are also present

the increase in cellularity is most obvious in the synovial membrane, which becomes infiltrated by cells recruited from the blood

the most abundant cells of the pannus are macrophages and T lymphocytes, but plasma cells, dendritic cells and activated fibroblasts are also found

inflammation in the synovium will grow into the joint and start eroding the bone and cartilage

61
Q

what effects does RA have on the body outside of the joints?

A
  1. episcleritis
  2. digital infarct
  3. rheumatoid nodules
    pulmonary fibrosis
  4. pleural effusion/pleurisy/lung nodules
  5. pericarditis/myocarditis/valvular heart disease
62
Q

what are the two treatment options for RA?

A
  1. disease modifying drugs (DMARDs)

2. immunosuppressive drugs

63
Q

which DMARDs are used to treat RA?

A
  1. hydroxychloroquine
  2. minocycline
  3. sulfasalazine, hydroxychloroquine
64
Q

which immunosuppressive drugs are used to treat RA?

A
  1. methotrexate
  2. azathioprine
  3. cyclophosphamide
  4. cyclosporine
65
Q

what are the newer therapies for RA?

A
1. Anti-TNF-α:
 Monoclonal antibody:
Infliximab.
Adalimumab.
	Soluble TNF receptor: 
Etanercept.
  1. Anti-IL1: IL1-Ra, anakinra.
  2. Anti-IL6 receptor antibody, tocilizumab.
  3. Anti-B cells: rituximab.
  4. Costimulatory molecules inhibitors: abatacept.
66
Q

what is systemic sclerosis?

A

SSc is a chronic systemic autoimmune disease that targets skin, lung, heart, GI tract, kidneys, and the musculoskeletal system

the pathology is characterized by immune activation and widespread & progressive vasculopathy and tissue fibrosis

skin isn’t stretchy

67
Q

which antibodies are related to scleroderma?

A

centromere

Scl70

RNA pol III

68
Q

what are the major clinical complications of SSc?

A

Extensive skin fibrosis and musculoskeletal disorder including myopathy

Interstitial lung disease and pulmonary fibrosis

Pulmonary arterial hypertension

Diastolic cardiac dysfunction (stiff heart)

Digital ischemic ulcers

Malabsorption and GI dysmotility

Renal crisis and renal vascular disease